Breakthrough in GMP-compliant iPSC therapy for recessive dystrophic epidermolysis bullosa (RDEB) treatment using genetically reprogrammed skin cells.
Exploring how induced pluripotent stem cells (iPSCs) and CRISPR technologies are transforming regenerative medicine and disease treatment.